Skip to main content
. 2022 Mar 8;19(6):3178. doi: 10.3390/ijerph19063178

Figure 1.

Figure 1

Main pathways for treatment of melanoma. * Adjuvant systemic therapies for resectable stage III melanoma or ipilimumab, dabrafenib/trametinib for unresectable stage III or IV melanoma are not subsidised in NZ, and these were omitted from the NZ model, and interferon therapy was added. SLNB = sentinel lymph node biopsy.